Application Nr Approved Date Route Status External Links
ANDA090222 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Bacterial Vaginosis (Bv). Metronidazole Extended-Release Tablets, 750 Mg Are Indicated In The Treatment Of Women With Bv. To Reduce The Development Of Drug-Resistant Bacteria And Maintain The Effectiveness Of Metronidazole Extended-Release Tablet And Other Antibacterial Drugs, Metronidazole Extended-Release Tablet Should Be Used Only To Treat Or Prevent Infections That Are Proven Or Strongly Suspected To Be Caused By Susceptible Bacteria. When Culture And Susceptibility Information Are Available, They Should Be Considered In Selecting Or Modifying Antibacterial Therapy. In The Absence Of Such Data, Local Epidemiology And Susceptibility Patterns May Contribute To The Empiric Selection Of Therapy.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Metronidazole METRONIDAZOLE ZINC113442

Comments